EUVIMEDEUVIMED entdecken
Open Access

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Ravi B Parikh, Yasin Civelek, Pelin Ozluk, David Debono, Michael J Fisch, Gosia Sylwestrzak, Justin E Bekelman, Aaron L Schwartz

The American Journal of Managed Care · 2024

DOI: 10.37765/ajmc.2024.89530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Managed Care, 2024. Verfasst von Ravi B Parikh und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, 423 Guardian Dr, Blockley 1102, Philadelphia, PA 19104. Email: ravi.parikh@pennmedicine.upenn.edu. Hauptthemen laut MEDLINE: COVID-19, Antiemetics, Breast Neoplasms, Medicare Part C. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the association between the onset of the COVID-19 pandemic and change in low-value cancer services. STUDY DESIGN: In this retrospective cohort study, we used administrative claims from the HealthCore Integrated Research Environment, a repository of medical and pharmacy data from US health plans representing more than 80 million members, between January 1, 2016, and March 31, 2021. METHODS: We used linear probability models to investigate the relation between the onset of the COVID-19 pandemic and 4 guideline-based metrics of low-value cancer care: (1) conventional fractionation radiotherapy instead of hypofractionated radiotherapy for early-stage breast cancer; (2) non-guideline-based antiemetic use for minimal-, low-, or moderate- to high-risk chemotherapies; (3) off-pathway systemic therapy; and (4) aggressive end-of-life care. We identified patients with new diagnoses of breast, colorectal, and/or lung cancer. We excluded members who did not have at least 6 months of continuous insurance coverage and members with prevalent cancers. RESULTS: Among 117,116 members (median [IQR] age, 60 [53-69] years; 72.4% women), 59,729 (51.0%) had breast cancer, 25,751 (22.0%) had colorectal cancer, and 31,862 (27.2%) had lung cancer. The payer mix was 18.7% Medicare Advantage or Medicare supplemental and 81.2% commercial non-Medicare. Rates of low-value cancer services exhibited minimal changes during the pandemic, as adjusted percentage-point differences were 3.93 (95% CI, 1.50-6.36) for conventional radiotherapy, 0.82 (95% CI, -0.62 to 2.25) for off-pathway systemic therapy, -3.62 (95% CI, -4.97 to -2.27) for non-guideline-based antiemetics, and 2.71 (95% CI, -0.59 to 6.02) for aggressive end-of-life care. CONCLUSIONS: Low-value cancer care remained prevalent throughout the pandemic. Policy makers should consider changes to payment and incentive design to turn the tide against low-value cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AntiemeticsBreast NeoplasmsMedicare Part CLung NeoplasmsHumansFemaleAgedUnited StatesMiddle AgedMalePandemicsRetrospective Studies

Substanzen

Antiemetics

Autor:innen und Institutionen

  • University of Pennsylvania, 423 Guardian Dr, Blockley 1102, Philadelphia, PA 19104. Email: ravi.parikh@pennmedicine.upenn.edu.

Förderung

  • HSRD VA
  • NCI NIH HHS

Zitieren

APA

Parikh, R. B., Civelek, Y., Ozluk, P., Debono, D., Fisch, M. J., Sylwestrzak, G., Bekelman, J. E., & Schwartz, A. L. (2024). Trends in Low-Value Cancer Care During the COVID-19 Pandemic. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2024.89530

Vancouver

Parikh RB, Civelek Y, Ozluk P, Debono D, Fisch MJ, Sylwestrzak G, et al. Trends in Low-Value Cancer Care During the COVID-19 Pandemic. The American Journal of Managed Care. 2024. doi:10.37765/ajmc.2024.89530

BibTeX
@article{Parikh2024,
  author = {Parikh, Ravi B and Civelek, Yasin and Ozluk, Pelin and Debono, David and Fisch, Michael J and Sylwestrzak, Gosia and Bekelman, Justin E and Schwartz, Aaron L},
  title = {Trends in Low-Value Cancer Care During the COVID-19 Pandemic},
  journal = {The American Journal of Managed Care},
  year = {2024},
  doi = {10.37765/ajmc.2024.89530}
}
Kostenlos starten →